西点药业：硫酸氨基葡萄糖胶囊注册申请获受理

中国08-09

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！中证智能财讯西点药业（301130）8月9日午间公告，公司近日收到国家药监局签发的硫酸氨基葡萄糖胶囊境内生产药品注册上市许可（金麒麟分析师）《受理通知书》。硫酸氨基葡萄糖胶囊用于原发性或继发性骨关节炎。截至公告披露之日，已获得硫酸氨基葡萄糖胶囊注册批件的国内药品生产企业为12家。资料显示，西点药业主要从事化学药品原料药及制剂...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2458535890?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-08-09 13:02","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2458535890","market":"hk","top_or_hot":-1,"title":"西点药业：硫酸氨基葡萄糖胶囊注册申请获受理","media":"中国","content":"<div>\n<p>炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 中证智能财讯西点药业（301130）8月9日午间公告，公司近日收到国家药监局签发的硫酸氨基葡萄糖胶囊境内生产药品注册上市许可（金麒麟分析师）《受理通知书》。硫酸氨基葡萄糖胶囊用于原发性或继发性骨关节炎。截至公告披露之日，已获得硫酸氨基葡萄糖胶囊注册批件的国内药品生产企业为12家。资料显示，西点药业主要从事化学药品原料药及制剂...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/relnews/cn/2024-08-09/doc-inchzpnf7560983.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>西点药业：硫酸氨基葡萄糖胶囊注册申请获受理</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n西点药业：硫酸氨基葡萄糖胶囊注册申请获受理\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-09 13:02 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/relnews/cn/2024-08-09/doc-inchzpnf7560983.shtml><strong>中国</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 中证智能财讯西点药业（301130）8月9日午间公告，公司近日收到国家药监局签发的硫酸氨基葡萄糖胶囊境内生产药品注册上市许可（金麒麟分析师）《受理通知书》。硫酸氨基葡萄糖胶囊用于原发性或继发性骨关节炎。截至公告披露之日，已获得硫酸氨基葡萄糖胶囊注册批件的国内药品生产企业为12家。资料显示，西点药业主要从事化学药品原料药及制剂...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/relnews/cn/2024-08-09/doc-inchzpnf7560983.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"301130","symbol_name":"西点药业","start_time":0,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-08-09/doc-inchzpnf7560983.shtml","article_id":"2458535890","we_media_id":null,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-08-09/doc-inchzpnf7560983.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2458535890","pubTimestamp":1723179720,"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"中证智能财讯西点药业8月9日午间公告，公司近日收到国家药监局签发的硫酸氨基葡萄糖胶囊境内生产药品注册上市许可《受理通知书》。硫酸氨基葡萄糖胶囊用于原发性或继发性骨关节炎。截至公告披露之日，已获得硫酸氨基葡萄糖胶囊注册批件的国内药品生产企业为12家。2024年第一季度，公司实现营业总收入6670.55万元，同比增长20.32%；净利润1404.28万元，同比增长46.66%。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"301130":"西点药业","BK0239":"医药制造"},"translate_title":"West Point Pharmaceutical: Application for registration of glucosamine sulfate capsules accepted","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"301130":1},"content_text":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 中证智能财讯西点药业（301130）8月9日午间公告，公司近日收到国家药监局签发的硫酸氨基葡萄糖胶囊境内生产药品注册上市许可（金麒麟分析师）《受理通知书》。硫酸氨基葡萄糖胶囊用于原发性或继发性骨关节炎。截至公告披露之日，已获得硫酸氨基葡萄糖胶囊注册批件的国内药品生产企业为12家。资料显示，西点药业主要从事化学药品原料药及制剂的研发、生产、销售于一体，“原料+制剂”双核驱动的制药企业。2024年第一季度，公司实现营业总收入6670.55万元，同比增长20.32%；净利润1404.28万元，同比增长46.66%。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2458535890"}